📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Ajmaline blocks INa and IKr without eliciting differences between Brugada syndrome patient and control human pluripotent stem cell-derived cardiac clusters. (2017)

First Author: Miller DC

Attributed to: The new LAW of microRNA-mediated gene silencing funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.scr.2017.11.003

PubMed Identifier: 29172153

Publication URI: http://europepmc.org/abstract/MED/29172153

Type: Journal Article/Review

Volume: 25

Parent Publication: Stem cell research

ISSN: 1873-5061